Perspective - Part III: Retrobulbar irradiation in Graves orbitopathy: The Dutch experience

Ophthalmic Plastic and Reconstructive Surgery

Volumn 18, Issue 3, 2002, Pages 175-176

  Wiersinga, Wilmar M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE; PREDNISONE;

CANCER; CANCER RISK; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFECT; DRUG RESPONSE; ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HAIR LOSS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RELAXATION TIME; RISK FACTOR; SHORT SURVEY; TREATMENT INDICATION;

EID: 0036106191     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002341-200205000-00004     Document Type: Short Survey

References (7)

1. Management of Graves' ophthalmopathy: Reality and perspectives
2. An evidence-based approach to the treatment of Graves' ophthalmopathy
3. Choice of therapy and criteria for assessing therapeutic outcome in thyroid-associated ophthalmopathy
4. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy
5. Radiotherapy for Graves' orbitopathy: Randomised placebo-controlled study
6. A randomized placebo-controlled study on radiotherapy for mild Graves' ophthalmopathy
7. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy